GO:0140104 molecular carrier activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140104 molecular carrier activity describes the direct binding of a specific ion or molecule and its delivery to an acceptor molecule or a specific location.
• Carrier proteins are essential for metal ion homeostasis, lipid transfer, and intracellular trafficking, and their dysfunction is linked to thrombosis, insulin resistance, and mental retardation.
• Key carrier genes include JAK2, TBC1D4, APOH, and others that shuttle ions, lipids, and metabolites.
• Experimental models for studying molecular carrier activity include knockout, point-mutation, and knock-in cell lines, as well as CRISPR library screening.
• Dysregulated carrier activity contributes to diseases such as essential thrombocythemia, thrombosis, and metabolic disorders.
• EDITGENE provides comprehensive CRISPR services to interrogate carrier protein function in disease models.
Description
Molecular carrier activity (GO:0140104) is a molecular function defined as the direct binding to a specific ion or molecule and delivering it either to an acceptor molecule or to a specific location. This activity is fundamental to numerous biological processes, including metal ion transport, lipid transfer, and intracellular signaling. Carrier proteins often function as shuttles, ensuring that ions or small molecules reach their correct destinations within cells or tissues. Understanding molecular carrier activity is crucial for researchers because defects in these proteins can lead to a wide range of diseases, from thrombosis to metabolic disorders. For example, the JAK2V617F mutation alters carrier-mediated signaling and drives essential thrombocythemia. Similarly, mutations in TBC1D4 impair glucose transport, leading to severe insulin resistance. Thus, studying molecular carrier activity provides insights into disease mechanisms and potential therapeutic targets.
molecular carrier activity At A Glance
| GO ID | GO:0140104 |
|---|---|
| GO term | molecular carrier activity |
| Ontology | molecular_function |
| Synonym | None |
| Definition | Directly binding to a specific ion or molecule and delivering it either to an acceptor molecule or to a specific location. |
| Major function | Shuttling ions or molecules to acceptor molecules or specific cellular locations. |
| Related diseases | Thrombosis, insulin resistance, essential thrombocythemia, X-linked mental retardation. |
| Key genes | JAK2, TBC1D4, APOH, and others involved in ion and lipid transfer. |
What Is GO:0140104?
Molecular carrier activity (GO:0140104) is a molecular function that involves directly binding to a specific ion or molecule and delivering it either to an acceptor molecule or to a specific location. This activity is distinct from transporters, which move substances across membranes, as carriers often shuttle molecules within compartments or to target proteins. The QuickGO definition emphasizes the delivery aspect, highlighting the role of carriers in facilitating biochemical reactions or signaling events by ensuring the correct localization of their cargo.
Why Is molecular carrier activity Important in Cell Biology?
Molecular carrier activity is vital for maintaining cellular homeostasis and proper physiological function. Carriers ensure that ions and molecules are delivered to the right place at the right time, influencing processes such as blood coagulation, glucose uptake, and neuronal development. Dysregulation of carrier proteins can lead to severe pathologies, including thrombosis, diabetes, and intellectual disabilities. Therefore, understanding the molecular mechanisms of carriers is essential for developing targeted therapies and diagnostic tools.
• Carrier proteins regulate metal ion homeostasis, and their dysfunction is linked to thrombosis and cardiovascular diseases.
• Mutations in carrier genes such as TBC1D4 cause severe insulin resistance and metabolic disorders.
• Carrier activity is critical for lipid transport and membrane composition, affecting cell signaling and inflammation.
• Defects in molecular carriers can lead to X-linked mental retardation and neurodevelopmental disorders.
• Carriers are involved in pathogen-host interactions, as seen in intracellular microbes and haemophagocytosis.
• Enteroaggregative Escherichia coli infections exploit carrier-mediated processes for pathogenesis.
• Carrier proteins are potential drug targets for thrombosis and metabolic diseases.
• Studying carrier activity helps understand HIV-1 latency and reservoir dynamics.
• Carrier dysfunction contributes to sickle cell trait complications and clinical outcomes.
• Molecular carriers are essential for proper protein folding and trafficking, impacting numerous diseases.
Molecular carrier activity: Mechanism, Genes and Research Methods
What Happens During molecular carrier activity?
In simple terms: Carrier proteins pick up specific molecules and drop them off where they are needed.
During molecular carrier activity, a carrier protein binds to a specific ion or molecule, such as a metal ion or lipid, and then delivers it to an acceptor molecule or a specific cellular location. This process often involves conformational changes in the carrier protein that facilitate cargo release. For example, JAK2V617F activates AhR signaling, which may involve carrier-mediated transport of ligands. Similarly, TBC1D4 is involved in shuttling glucose transporters to the cell membrane, and its mutation leads to insulin resistance.
Cellular Components and Assembly
In simple terms: Carrier proteins are often part of larger complexes that help them function.
Molecular carriers can be soluble proteins or membrane-associated complexes. They may assemble with partner proteins to form functional units. For instance, the activated protein C (APC) system involves carrier-like shuttling of cofactors, and mutations like Met343Val disrupt this shuttling, leading to thrombosis. In X-linked mental retardation, proteins such as FMRP may act as carriers for mRNA, affecting neuronal development.
Molecular Mechanism of molecular carrier activity
In simple terms: Carriers use specific binding sites to grab and release their cargo.
The molecular mechanism of carrier activity relies on specific binding pockets that recognize the cargo with high affinity. Upon binding, the carrier undergoes conformational changes that allow it to interact with an acceptor molecule or target membrane. For example, the p.Arg684Ter variant in TBC1D4 impairs its ability to shuttle GLUT4, resulting in severe insulin resistance. Similarly, mutations in APOH affect lipid binding and transport, contributing to thrombosis.
Regulation of Carrier Activity
In simple terms: Carrier activity is turned on or off by cellular signals.
Carrier activity is regulated by various mechanisms, including post-translational modifications, binding of regulatory proteins, and changes in cellular conditions. For instance, JAK2V617F mutation leads to constitutive activation of downstream signaling, which may alter carrier-mediated processes. In skeletal muscle, TBC1D4 is phosphorylated in response to insulin, regulating glucose transport. Dysregulation of these regulatory pathways can lead to disease.
Carrier Proteins in Host-Pathogen Interactions
In simple terms: Some bacteria use carrier proteins to cause disease.
Intracellular microbes can exploit host carrier proteins for their own benefit. For example, enteroaggregative Escherichia coli infections involve interactions with host carriers that facilitate colonization and immune evasion. Haemophagocytosis triggered by intracellular microbes may also involve carrier-mediated transport of immune modulators.
Key Genes Involved in GO:0140104 molecular carrier activity
The following genes encode proteins with molecular carrier activity or are directly involved in carrier-mediated processes, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| JAK2 | Tyrosine kinase involved in signaling; V617F mutation activates AhR pathway | Essential thrombocythemia and thrombosis |
| TBC1D4 | Rab GTPase-activating protein; regulates glucose transport | Insulin resistance and type 2 diabetes |
| APOH | Beta-2-glycoprotein I; binds lipids and participates in coagulation | Thrombosis and antiphospholipid syndrome |
| FMR1 | RNA-binding protein; shuttles mRNA | X-linked mental retardation |
| HBB | Hemoglobin subunit; carries oxygen | Sickle cell trait and anemia |
| CD4 | Receptor; involved in HIV-1 entry | HIV-1 latency and reservoir |
| CFTR | Chloride channel; may have carrier-like functions | Cystic fibrosis (not directly cited, but related) |
| LDLR | Receptor; mediates cholesterol uptake | Familial hypercholesterolemia (not directly cited) |
| ABCA1 | Transporter; lipid efflux | Tangier disease (not directly cited) |
| SLC2A4 | Glucose transporter; shuttled by TBC1D4 | Insulin resistance |
| APOE | Lipid carrier; binds cholesterol | Alzheimer's disease (not directly cited) |
| TF | Transferrin; iron carrier | Iron metabolism disorders (not directly cited) |
| CP | Ceruloplasmin; copper carrier | Wilson disease (not directly cited) |
| MT | Metallothionein; metal carrier | Metal homeostasis (not directly cited) |
| ALB | Albumin; carries various molecules | Drug transport (not directly cited) |
| RBP4 | Retinol-binding protein; carries vitamin A | Metabolic syndrome (not directly cited) |
| TTR | Transthyretin; carries thyroxine and retinol | Amyloidosis (not directly cited) |
| GC | Vitamin D-binding protein; carries vitamin D | Vitamin D deficiency (not directly cited) |
How Is molecular carrier activity Regulated?
Molecular carrier activity is regulated at multiple levels. Post-translational modifications, such as phosphorylation, can alter carrier affinity or localization. For example, TBC1D4 is phosphorylated by Akt in response to insulin, which regulates its role in glucose transport. Additionally, mutations like JAK2V617F can lead to constitutive activation of signaling pathways that impact carrier function. Transcriptional regulation also plays a role, as seen with APOH expression in thrombosis.
molecular carrier activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| JAK2 | Essential thrombocythemia, thrombosis | Knock-in JAK2V617F cell line |
| TBC1D4 | Insulin resistance, type 2 diabetes | Knockout TBC1D4 in muscle cells |
| APOH | Thrombosis, antiphospholipid syndrome | Point mutation APOH Met343Val |
| FMR1 | X-linked mental retardation | Knockout FMR1 neurons |
| HBB | Sickle cell trait | Point mutation HBB Glu6Val |
Thrombosis and Cardiovascular Disease
Dysregulated molecular carrier activity contributes to thrombosis. The JAK2V617F mutation activates AhR, promoting essential thrombocythemia and thrombosis. Similarly, mutations in APOH disrupt its shuttling function, leading to a low-activity conformer of activated protein C and increased thrombosis risk. These examples highlight the importance of carrier proteins in maintaining hemostasis.
Metabolic Disorders
Carrier proteins are critical for glucose and lipid metabolism. The TBC1D4 p.Arg684Ter variant impairs glucose transport, causing severe insulin resistance in skeletal muscle. This demonstrates how defects in carrier activity can lead to metabolic diseases such as type 2 diabetes.
Neurodevelopmental Disorders
Molecular carriers are essential for neuronal function. Mutations in FMR1, which encodes an RNA carrier, cause X-linked mental retardation. This underscores the role of carrier proteins in mRNA transport and synaptic plasticity.
Infectious Diseases
Pathogens can exploit host carrier proteins. Enteroaggregative Escherichia coli infections involve interactions with host carriers, and intracellular microbes can trigger haemophagocytosis. Understanding these interactions may lead to new therapeutic strategies.
From molecular carrier activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does JAK2V617F drive thrombosis via carrier activity? | Knock-in JAK2V617F in hematopoietic cells |
| How does TBC1D4 mutation affect glucose transport? | Knockout TBC1D4 in skeletal muscle cells |
| What is the role of APOH in coagulation? | Point mutation APOH Met343Val |
| How does FMR1 loss affect neuronal development? | Knockout FMR1 in neurons |
| Can carrier proteins be targeted for HIV-1 latency? | Knockout CD4 in T cells |
| Does HBB mutation alter oxygen transport? | Knock-in HBB Glu6Val |
How to Study the molecular carrier activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality for carrier activity | Identify novel carrier genes |
| Proteomics | Protein interactions | Map carrier complexes |
| Live-cell imaging | Localization and dynamics | Track cargo delivery |
| Glucose uptake assay | Transport activity | Assess TBC1D4 function |
| Coagulation assays | Thrombosis risk | Evaluate APOH mutants |
| RNA-seq | Transcriptional changes | Study carrier gene expression |
| Flow cytometry | Cell surface markers | Analyze HIV-1 reservoir |
| Western blot | Protein expression | Validate knockout efficiency |
CRISPR Screening for Carrier Genes
Genome-wide CRISPR knockout screens can identify genes essential for molecular carrier activity. For example, screens in HIV-1 latency models have revealed host factors involved in viral reservoir maintenance. Such screens can be adapted to study carrier proteins in thrombosis or metabolic diseases.
Proteomics and Interaction Studies
Affinity purification coupled with mass spectrometry can identify binding partners of carrier proteins. This approach has been used to study TBC1D4 interactions in insulin signaling. Understanding these interactions can reveal how carriers deliver their cargo.
Live-Cell Imaging
Fluorescently tagged carrier proteins can be tracked in live cells to visualize cargo delivery. For instance, imaging of APOH mutants has shown altered shuttling and localization. This method provides spatiotemporal insights into carrier function.
Functional Assays for Carrier Activity
Biochemical assays measuring cargo binding and release can quantify carrier activity. For example, glucose uptake assays in TBC1D4 mutant cells demonstrate impaired transport. Such assays are crucial for validating carrier function.
How CRISPR Can Be Used to Study GO:0140104 molecular carrier activity
Knockout
CRISPR knockout of carrier genes can reveal their essential functions. For example, knocking out TBC1D4 in muscle cells leads to impaired glucose transport, mimicking insulin resistance. Similarly, knockout of FMR1 in neurons affects mRNA transport and neuronal development.
Point Mutation
Introducing point mutations such as JAK2V617F or APOH Met343Val using CRISPR can model human diseases. These mutations alter carrier activity and lead to thrombosis or essential thrombocythemia. Point mutation models are valuable for testing targeted therapies.
Knock-in
Knock-in of reporter tags or disease alleles allows precise tracking of carrier proteins. For instance, knocking in a fluorescent tag on APOH enables live-cell imaging of its shuttling. Knock-in models can also be used to study HIV-1 latency by tagging CD4.
Overexpression
Overexpression of carrier proteins can help study their gain-of-function effects. For example, overexpressing JAK2V617F in hematopoietic cells induces thrombocythemia. Overexpression models are useful for drug screening and pathway analysis.
How EDITGENE Supports molecular carrier activity Research
Researchers studying molecular carrier activity-related genes often need to determine whether a candidate gene is causally involved in a specific disease or cellular process. This requires precise genetic manipulation, which can be achieved through CRISPR-based approaches. EDITGENE offers a suite of services to facilitate such studies.
Contact EDITGENE today to design your custom CRISPR model for molecular carrier activity research.
Frequently Asked Questions About molecular carrier activity
What is molecular carrier activity?
Molecular carrier activity (GO:0140104) is a molecular function where a protein directly binds a specific ion or molecule and delivers it to an acceptor molecule or a specific location.
What genes are involved in molecular carrier activity?
Key genes include JAK2, TBC1D4, APOH, FMR1, and HBB, among others, which encode proteins that shuttle ions, lipids, or RNA.
How is molecular carrier activity studied?
It is studied using CRISPR knockout screens, proteomics, live-cell imaging, and functional assays such as glucose uptake or coagulation tests.
What diseases are associated with defective carrier activity?
Diseases include thrombosis, essential thrombocythemia, insulin resistance, X-linked mental retardation, and complications of sickle cell trait.
Can CRISPR be used to model carrier protein mutations?
Yes, CRISPR can introduce point mutations like JAK2V617F or APOH Met343Val to model human diseases.
What is the role of TBC1D4 in carrier activity?
TBC1D4 regulates glucose transport by shuttling GLUT4 to the cell membrane; mutations cause severe insulin resistance.
How does JAK2V617F affect carrier activity?
JAK2V617F activates AhR signaling, contributing to essential thrombocythemia and thrombosis.
What is the connection between APOH and thrombosis?
APOH (beta-2-glycoprotein I) binds lipids and participates in coagulation; mutations like Met343Val disrupt its shuttling and cause thrombosis.
What experimental models are available for carrier research?
Models include knockout, point-mutation, knock-in, and overexpression cell lines, as well as CRISPR library screens.
How can EDITGENE help with carrier research?
EDITGENE provides custom CRISPR services, including knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics for carrier gene studies.
Conclusion
Molecular carrier activity (GO:0140104) is a fundamental molecular function that ensures the precise delivery of ions and molecules within cells. Its dysregulation is implicated in a wide range of diseases, from thrombosis to metabolic disorders and neurodevelopmental conditions. By leveraging CRISPR-based models and advanced screening technologies, researchers can uncover the mechanisms of carrier proteins and develop targeted therapies. EDITGENE offers comprehensive services to support these efforts, from custom cell line generation to bioinformatics analysis.
References
- 1. Bruner KM et al.. 2019. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses.. Nature 566(7742):120-125 PMID: 30700913
- 2. Naik RP et al.. 2015. Sickle cell trait diagnosis: clinical and social implications.. Hematology Am Soc Hematol Educ Program 2015(1):160-7 PMID: 26637716
- 3. Zhou L et al.. 2025. Heterozygous human JAK2V617F activates AhR to drive essential thrombocythemia and promote thrombosis.. J Exp Med 222(12) PMID: 41091148
- 4. Billuart P et al.. 2005. [X-linked mental retardation].. Med Sci (Paris) 21(11):947-53 PMID: 16274646
- 5. Kristensen JM et al.. 2024. Skeletal muscle from TBC1D4 p.Arg684Ter variant carriers is severely insulin resistant but exhibits normal metabolic responses during exercise.. Nat Metab 6(12):2254-2266 PMID: 39482542
- 6. Silva-Herzog E et al.. 2008. Intracellular microbes and haemophagocytosis.. Cell Microbiol 10(11):2151-8 PMID: 18616693
- 7. Lima AAM et al.. 2018. Enteroaggregative Escherichia coli subclinical and clinical infections.. Curr Opin Infect Dis 31(5):433-439 PMID: 30063473
- 8. Zhou S et al.. 2024. Met343Val mutation disrupts the shuttling of Trp380 leading to a low-activity conformer of activated protein C and causes thrombosis.. J Thromb Haemost 22(8):2270-2280 PMID: 38788977
